Morgan Stanley Ice Cure Medical Ltd. Transaction History
Morgan Stanley
- $1.36 Trillion
- Q1 2025
A detailed history of Morgan Stanley transactions in Ice Cure Medical Ltd. stock. As of the latest transaction made, Morgan Stanley holds 700 shares of ICCM stock, worth $700. This represents 0.0% of its overall portfolio holdings.
Number of Shares
700
Previous 6,069
88.47%
Holding current value
$700
Previous $6,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding ICCM
# of Institutions
17Shares Held
161KCall Options Held
0Put Options Held
0-
Geode Capital Management, LLC Boston, MA40.5KShares$40,4530.0% of portfolio
-
Xtx Topco LTD London, X021.9KShares$21,8760.0% of portfolio
-
Gunderson Capital Management Inc.20KShares$20,0000.01% of portfolio
-
Lpl Financial LLC Fort Mill, SC18.9KShares$18,8750.0% of portfolio
-
Foundations Investment Advisors, LLC15KShares$15,0000.0% of portfolio
About IceCure Medical Ltd.
- Ticker ICCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 36,835,600
- Market Cap $36.8M
- Description
- IceCure Medical Ltd, a medical device company, engages in the research, development, and commercialization of medical devices for cryoablation (freezing) of tumors in the human body. It offers ProSense system, a cryoablation solution for the treatment of breast tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.